Bronkosol side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Bronkosol. Common side effects include drug hypersensitivity among females, and arthralgia among males.
The phase IV clinical study is created by eHealthMe based on 2 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Bronkosol and have side effects are studied.
What is Bronkosol?
Bronkosol has active ingredients of isoetharine hydrochloride. Currently, eHealthMe is studying from 2 Bronkosol users.
Number of Bronkosol reports submitted per year:
Bronkosol side effects by gender *:
female:
- Drug hypersensitivity
male:
- Arthralgia (joint pain)
Bronkosol side effects by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
- Arthralgia (joint pain)
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Drug hypersensitivity
* Approximation only. Some reports may have incomplete information.
Do you take Bronkosol?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on isoetharine hydrochloride (the active ingredients of Bronkosol) and Bronkosol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Bronkosol:
- Bronkosol (2 reports)
All Bronkosol side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ultracet and Pegasys drug interaction - now
- Oxybutynin Chloride and Doxycycline drug interaction - 9 seconds ago
- Sodium Chloride and Rebound Effect - 12 seconds ago
- Gemzar and Rubraca drug interaction - 16 seconds ago
- Azor and Gout - 18 seconds ago
- Stalevo 100 and Trileptal drug interaction - 20 seconds ago
- Orencia and Fungizone drug interaction - 20 seconds ago
- Mefenamic Acid and Stavudine drug interaction - 22 seconds ago
- Dramamine and Aubagio drug interaction - 29 seconds ago
- Implanon and Implant Site Cellulitis - 30 seconds ago